 |
mesylate synthetic small molecule inhibitor of HDAC and PI3K |
|---|---|
| Trade Name | |
| Orphan Indication | Nuclear protein in testis (NUT) midline carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 2016-09-06 00:00:00 |
| Sponsor | Curis, Inc.;4 Maguire Road;Lexington, Massachusetts, 02421 |
